Skip to content

Clinical trials

Phase 4 Lung Diseases, Interstitial trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Diseases, Interstitial Phase: Phase 4 Clear all

26 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20071
20081
20091
20142
20151
20163
20171
20192
20203
20211
20223
20232
20241
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Unknown status7
Not yet recruiting3
Recruiting2
Withdrawn1
Suspended1
Terminated1
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Post Graduate Institute of Medical Education and Research, Chandigarh4
Qilu Hospital of Shandong University2
University of Zurich2
Daniel Franzen1
Duke University1
First Affiliated Hospital Xi'an Jiaotong University1
Icahn School of Medicine at Mount Sinai1
KU Leuven1
National Institute for Tuberculosis and Lung Diseases, Poland1
Peking University Third Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Diseases, Interstitial26
Pulmonary Fibrosis5
Sarcoidosis5
Hypertension, Pulmonary4
Myositis4
Arthritis, Rheumatoid3
Connective Tissue Diseases3
Alveolitis, Extrinsic Allergic2
COVID-192
Dermatomyositis2

Trials

Showing 26 to 26 of 26. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.